Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients

被引:28
|
作者
Garcia-Azorin, David [1 ,2 ]
Trigo, Javier [1 ]
Talavera, Blanca [1 ]
Martinez-Pias, Enrique [1 ]
Sierra, Alvaro [1 ]
Porta-Etessam, Jesus [3 ,4 ]
Arenillas, Juan F. [1 ,5 ,6 ]
Guerrero, Angel L. [1 ,2 ,6 ]
机构
[1] Hosp Clin Univ Valladolid, Dept Neurol, Headache Unit, Ave Ramon y Cajal 3, Valladolid 47005, Spain
[2] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain
[3] Hosp Clin San Carlos, IdISSC, Inst Neurosci, Headache Unit,Dept Neurol, Madrid, Spain
[4] Univ Complutense Madrid, Dept Med, Madrid, Spain
[5] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Neurovasc Res Lab, Madrid, Spain
[6] Univ Valladolid, Sch Med, Dept Med, Valladolid, Spain
来源
HEADACHE | 2020年 / 60卷 / 08期
关键词
Covid-19; neurology; headache; coronavirus; diagnosis; EMERGENCY-DEPARTMENT; MANAGEMENT; MIGRAINE; DISEASE;
D O I
10.1111/head.13927
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19. Background Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags. Design and Methods Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission. Results We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation: 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases. Conclusion In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.
引用
收藏
页码:1664 / 1672
页数:9
相关论文
共 50 条
  • [41] Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series Reply
    Gervasoni, Cristina
    Meraviglia, Paola
    Cattaneo, Dario
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : 2023 - 2023
  • [42] Headache prevalence in COVID-19 ambulatory patients
    NInashvili, N.
    Shavdia, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 111 - 111
  • [43] Headache prevalence in COVID-19 ambulatory patients
    NInashvili, N.
    Shavdia, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 74 - 74
  • [44] Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic
    Ma, Mengmeng
    Bao, Jiajia
    Fang, Jinghuan
    Li, Changling
    Li, Yanbo
    Ge, Wenjing
    Zhang, Yang
    Guo, Jian
    He, Li
    CURRENT NEUROVASCULAR RESEARCH, 2021, 18 (01) : 4 - 11
  • [45] Reality of Covid-19 vaccination in hospitalized patients
    Ramos-Bendezu, Ivette
    Rojas-Baldarrago, Cristofer
    Buleje, Jose
    SALUD PUBLICA DE MEXICO, 2023, 65 (02): : 187 - 188
  • [46] Atrial Fibrillation in Patients Hospitalized With COVID-19
    Musikantow, Daniel R.
    Turagam, Mohit K.
    Sartori, Samantha
    Chu, Edward
    Kawamura, Iwanari
    Shivamurthy, Poojita
    Bokhari, Mahmoud
    Oates, Connor
    Zhang, Chi
    Pumill, Christopher
    Malick, Waqas
    Hashemi, Helen
    Ruiz-Maya, Tania
    Hadley, Michael B.
    Gandhi, Jonathan
    Sperling, Dylan
    Whang, William
    Koruth, Jacob S.
    Langan, Marie-Noelle
    Sofi, Aamir
    Gomes, Anthony
    Harcum, Stephanie
    Cammack, Sam
    Ellsworth, Betsy
    Dukkipati, Srinivas R.
    Bassily-Marcus, Adel
    Kohli-Seth, Roopa
    Goldman, Martin E.
    Halperin, Jonathan L.
    Fuster, Valentin
    Reddy, Vivek Y.
    JACC-CLINICAL ELECTROPHYSIOLOGY, 2021, 7 (09) : 1120 - 1130
  • [47] Hydroxychloroquine in Hospitalized Patients with Covid-19 Reply
    Horby, Peter
    White, Nicholas J.
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 882 - 882
  • [48] Gastrointestinal Manifestation of COVID-19 in Hospitalized Patients
    Sukharani, Naintara
    Kumar, Jitesh
    Makheja, Kainat
    Bai, Pinky
    Sharma, Sucheta
    Subash, Komal
    Kamawal, Yasir
    Shahid, Simra
    Rizwan, Amber
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [49] Echocardiographic Findings in Hospitalized Patients With COVID-19
    Jehangir, Qasim
    Lee, Yi
    Poisson, Laila
    Latack, Katie
    Sule, Anupam
    Song, Shiyi
    Apala, Dinesh Reddy
    Halabi, Abdul R.
    Patel, Kirit
    Krishnamoorthy, Geetha
    Wang, Dee Dee
    CIRCULATION, 2021, 144
  • [50] Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
    Horby, Peter
    Mafham, Marion
    Linsell, Louise
    Bell, Jennifer L.
    Staplin, Natalie
    Emberson, Jonathan R.
    Wiselka, Martin
    Ustianowski, Andrew
    Elmahi, Einas
    Prudon, Benjamin
    Whitehouse, Tony
    Felton, Timothy
    Williams, John
    Faccenda, Jakki
    Underwood, Jonathan
    Baillie, J. Kenneth
    Chappell, Lucy C.
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Lim, Wei Shen
    Montgomery, Alan
    Rowan, Kathryn
    Tarning, Joel
    Watson, James A.
    White, Nicholas J.
    Juszczak, Edmund
    Haynes, Richard
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (21): : 2030 - 2040